Dieppe, Canada

Nir Shoham-Hazon

This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Hexiris Inc.. Active years: 2025-2026.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Nir Shoham-Hazon in Glaucoma Treatment

Introduction

Nir Shoham-Hazon is a notable inventor based in Dieppe, CA, recognized for his contributions to medical devices aimed at treating ocular disorders. With a total of 5 patents, he has made significant strides in the field of glaucoma treatment.

Latest Patents

One of his latest patents is focused on glaucoma shunts and related methods of use. This invention includes an elongate body with an outer surface and an inner surface, where the inner wall defines a lumen that spans the length of the body. The patent also describes methods for decreasing intraocular pressure in the eye by inserting a portion of the glaucoma shunt into the anterior chamber and draining aqueous humor through the lumen. Another significant patent is for a medical device and ocular implant designed for minimally invasive glaucoma surgeries. This device features a proximal segment for user grasping and a distal segment with a piercing member that delivers an ocular implant into eye tissue, creating a channel for treatment.

Career Highlights

Nir Shoham-Hazon works at Hexiris Inc., where he continues to innovate in the field of ophthalmology. His work focuses on developing advanced medical devices that enhance the effectiveness of glaucoma treatments.

Collaborations

He collaborates with Houfar Sekhavat, contributing to the advancement of medical technology in ocular health.

Conclusion

Nir Shoham-Hazon's innovative patents and dedication to improving glaucoma treatment highlight his significant role in the medical device industry. His work continues to pave the way for advancements in ocular health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…